STAGE IV PROSTATE CANCER AJCC V8
Clinical trials for STAGE IV PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could treating the primary tumor boost survival in advanced prostate cancer?
Disease control Recruiting nowThis study compares standard drug therapy alone versus standard therapy plus surgery or radiation to the prostate in men whose cancer has spread. The goal is to see if treating the original tumor improves overall survival. About 1,273 participants will be enrolled.
Matched conditions: STAGE IV PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
New drug combo shows promise in halting prostate cancer growth
Disease control Recruiting nowThis study tests whether adding a targeted drug called talazoparib to standard hormone therapy can better control prostate cancer that has spread but still responds to hormones. About 70 men with metastatic castration-sensitive prostate cancer will receive the combination. The go…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 15:40 UTC
-
Freezing tumors could double pain relief for bone metastases patients
Symptom relief Recruiting nowThis study tests whether adding cryoablation (freezing cancer cells) to standard radiation therapy provides better pain relief for people with cancer that has spread to their bones. About 40 adults with advanced cancers like prostate, colorectal, or melanoma will be randomly assi…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 15:38 UTC
-
Which prostate cancer drug has fewer side effects? new study aims to find out
Symptom relief Recruiting nowThis study compares the side effects of two standard treatments for advanced prostate cancer: abiraterone plus prednisone versus darolutamide alone. About 75 men with advanced prostate cancer will take one of these treatments, and researchers will track any serious side effects t…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC